ALPS Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $236K | Sell |
|
|||||
|
2024
Q4 | $240K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $111K | Sell |
|
|||||
|
2022
Q2 | $115K | Sell |
|
|||||
|
2022
Q1 | $528K | Sell |
|
|||||
|
2021
Q4 | $524K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $517K | Sell |
|
|||||
|
2020
Q2 | $421K | Sell |
|
|||||
|
2020
Q1 | $475K | Sell |
|
|||||
|
2019
Q4 | $728K | Buy |
|
|||||
|
2019
Q3 | $625K | Sell |
|
|||||
|
2019
Q2 | $913K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $207K | Sell |
|
|||||
|
2015
Q4 | $353K | Sell |
|
|||||
|
2015
Q3 | $3.42K | Buy |
|
|||||
|
2015
Q2 | $281K | Buy |
|
|||||
|
2015
Q1 | $156K | Buy |
|